drugset / Trial / NCT02381288

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

NCT02381288

Phase 2 Terminated 17 enrolled Takeda
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effects on serum testosterone (ST) after 6 weeks of subcutaneous (SC) administration of different doses and dosing frequencies of TAK-448 to middle-aged and older men with low ST levels.

Timeline

Start
2015-09-10
Primary completion
2016-04-08
Completion
2016-04-08

Drugs

EvaluationDrugModalityDoseRoute
Subject TAK-448 Small molecule 0.1 ug Subcutaneous
Subject TAK-448 Small molecule 0.3 ug Subcutaneous
Subject TAK-448 Small molecule 1 ug Subcutaneous

Indications